BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs

Rheumatology (Oxford). 2017 Feb 27. DOI:10.1093/rheumatology/kew479 [Epub ahead of print]

Ledingham J, Gullick N, Irving K, Gorodkin R, Aris M

https://www.ncbi.nlm.nih.gov/pubmed/28339817

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s